1. Brands where the patient may expect to pay less – most common strength . 2 2. All drugs with price reductions . 31
1. Brands where the patient may expect to pay less – most common strength
• Patient savings represent an expected maximum saving per script. • Different pharmacies may charge different amounts for medicines that cost less than the co-payment.
o This means that some patients will NOT save the full amount.
• Concessional patients will continue to pay $5.80 (plus any premiums if applicable). • Note that BOLD brands are those with brand premiums (extra patient surcharge) – therefore the old and
new prices are higher than the other brands, as is the potential maximum savings.
Patient’s commonly potential used form and strength Fosamax Once Weekly Patient’s commonly potential used form and strength Alprazolam Amiodarone Amlodipine Patient’s commonly potential used form and strength Amlodipine cont. Amlodipine Patient’s commonly potential used form and strength Amlodipine cont. Amoxycillin Patient’s commonly potential used form and strength Augmentin Duo forte
Amoxycillin/ Clavulanic Acid 875/125 generichealth
Chem mart Amoxycillin and Clavulanic Acid
Amoxycillin with Clavulanic Acid
Terry White Chemists Amoxycillin and Clavulanic Acid
Tenormin Atenolol
Patient’s commonly potential used form and strength Azathioprine Lioresal 10 Baclofen Captopril Carvedilol Patient’s commonly potential used form and strength
Terry White Chemists Carvedilol 3.125 mg
Ceclor CD Cefaclor Cephalexin Patient’s commonly potential used form and strength Ciprofloxacin Ciproxin 500 Patient’s commonly potential used form and strength Citalopram Cipramil Patient’s commonly potential used form and strength Citalopram Clarithromycin Anafranil 25 Clomipramine Codeine with Panadeine Forte Patient’s commonly potential used form and strength Paracetamol Diltiazem Enalapril Renitec 20 Patient’s commonly potential used form and strength Pepcidine Famotidine Plendil ER Felodipine Flucloxacillin Fluoxetine Prozac 20 Patient’s commonly potential used form and strength Fluvoxamine Frusemide Patient’s commonly potential used form and strength Gabapentin Gemfibrozil Glimepiride Patient’s commonly potential used form and strength Hydroxocobalamin Imdur Durule Isosorbide Mononitrate
Terry White Chemists Isosorbide Mononitrate
Lactulose Duphalac Patient’s commonly potential used form and strength Lamictal Lamotrigine Lansoprazole Patient’s commonly potential used form and strength Lercanidipine Lisinopril Prinivil 20 Patient’s commonly potential used form and strength Metformin Glucophage Patient’s commonly potential used form and strength Methotrexate Lopresor 50 Metoprolol Mirtazapine Patient’s commonly potential used form and strength Aurorix 300 mg Moclobemide Adalat Oros 30 Nifedipine Norfloxacin Patient’s commonly potential used form and strength Losec Tablets Omeprazole Pantoprazole Patient’s commonly potential used form and strength Paroxetine Perindopril Pravastatin Pravachol Patient’s commonly potential used form and strength Accupril Quinapril Ramipril Patient’s commonly potential used form and strength Roxithromycin Patient’s commonly potential used form and strength Sertraline Simvastatin Patient’s commonly potential used form and strength Simvastatin cont. Simvastatin Patient’s commonly potential used form and strength Simvastatin cont. Patient’s commonly potential used form and strength Sodium Chloride Normison Temazepam Topiramate Tramadol Patient’s commonly potential used form and strength Trandolapril 2. All drugs with price reductions Reduction Patient Save? Government Save?
Cardiac arrhythmia (irregular heartbeat)
Gastro-oesophageal reflux disease (GORD) and peptic ulcer
Reduction Patient Save? Government Save?
Gastro-oesophageal reflux disease (GORD) and peptic ulcer
Gastro-oesophageal reflux disease (GORD) and peptic ulcer
Omeprazole and Clarithromycin and Amoxycillin Peptic ulcer
Gastro-oesophageal reflux disease (GORD) and peptic ulcer
Reduction Patient Save? Government Save?
Cardiac arrhythmia (irregular heartbeat)
Comunicato uff.n° 21 DELLA CPG SEZIONE GIUDICANTE DELIBERE DEL 02/02/2012 PROT. N.RO BL/08/2012 IN QUESTO NUMERO: Comunicazioni importanti per le società Omologazione Risultati Classifiche Comunicazioni importanti per le società Nuovo indirizzo comitato provinciale Si comunica alle società che a far data 01 febbraio 2012, l’indirizzo postale per in
The appraised property can be found in the centre of Kecskemét, in Kálvin tér, in the external rim of the precincts (Kosssuth tér-Szabadság tér), beside Csányi körút open also for Due to central location of the area it is easily accessible both by public transportation and car, although the question of parking is not solved at all. Parking is possible only in the In the downtown area